Use of Non-GAAP Financial Measures
WuXi PharmaTech has provided the second quarter of 2007 net income and earnings per ADS on a non-GAAP basis, all excluding share-based compensation expenses. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing the Company's financial performance and liquidity and when planning and forecasting future periods. These non-GAAP operating measures are useful for understanding and assessing underlying business performance and operating trends. The Company expects to provide net income and earnings per ADS on a non-GAAP basis using a consistent method on a quarterly basis going forward.
Readers are cautioned not to view non-GAAP results on a stand-alone basis or as a substitute for results under GAAP, or as being comparable to results reported or forecasted by other companies, and should refer to the reconciliation of non-GAAP measures to GAAP measures for the indicated periods attached hereto.
Cautionary Note Regarding Forward-Looking Statements
Statements in this release contains "forward-looking" statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and as
defined in the Private Securities Litigation Reform Act of 1995, including,
among others, WuXi PharmaTech's anticipated operating results for 2007, our
expansion plan for the Jinshan manufacturing facility and the design of our
new preclinical drug safety evaluation center in Suzhou. These forward-
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2007 PR Newswire.
All rights reserved